A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain
Clinical trial NCT04442737 · COMPLETED
Trial details
- NCT number
- NCT04442737
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-08-07
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.